Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthconnROCO:6665 -1.94%81 EV-to-EBITDA is 9.63 as of Sep. 11, 2026, which is 8% above its 10-year median of 8.90. GuruFocus rates ROCO:6665 with a GF Score™ of 81/100 and a GF Value™ of NT$22.26 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 15 Healthcare Plans companies, Healthconn ranks better than 73.33% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Healthconn's enterprise value is NT$880 Mil.
Healthconn's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$91 Mil. Therefore, Healthconn's EV-to-EBITDA for today is 9.63.
The historical rank and industry rank for Healthconn's EV-to-EBITDA or its related term are showing as below:
ROCO:6665'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.03 Med: 8.9 Max: 47.86
Current: 9.62
During the past 12 years, the highest EV-to-EBITDA of Healthconn was 47.86. The lowest was 4.03. And the median was 8.90.
ROCO:6665's EV-to-EBITDA is ranked better than 73.33% of 15
companies
in the Healthcare Plans industry
Industry Median: 12.63
vs ROCO:6665: 9.62
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Healthconn's share price for today is NT$17.65.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Healthconn's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.474.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Healthconn's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6665 vs UNH, CVS, ELV: EV-to-EBITDA Comparison
For the Healthcare Plans subindustry, Healthconn's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthconn EV-to-EBITDA vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Healthconn's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Healthconn's EV-to-EBITDA falls into.
Healthconn's current Enterprise Value is NT$880 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Healthconn's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$91 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthconn (ROCO:6665) has a EV-to-EBITDA of 9.63 as of Sep. 11, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Healthconn. This is near median its historical median of 8.90. Over the past decade, Healthconn's EV-to-EBITDA has ranged from 4.03 to 47.86. According to the industry distribution chart, Healthconn ranks #4 out of 15 companies in the Healthcare Plans industry, placing it in the top 26.7%.
Is Healthconn's EV-to-EBITDA too high?
Healthconn's current EV-to-EBITDA of 9.63 is near median its 10-year median of 8.90. Over the past 10 years, this metric has ranged from a low of 4.03 to a high of 47.86. The Healthcare Plans industry median EV-to-EBITDA is 12.63. Healthconn's value of 9.63 is 23.8% below this industry median. Based on the distribution chart, Healthconn ranks #4 out of 15 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Healthconn has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthconn's EV-to-EBITDA compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Healthconn ranks #4 out of 15 companies for EV-to-EBITDA. This puts Healthconn in the upper half of its industry. The industry median EV-to-EBITDA is 12.63. Healthconn's value of 9.63 is 23.8% below this benchmark. Historically, Healthconn's own EV-to-EBITDA has ranged from 4.03 to 47.86 over the past decade. While the company's 10-year median is 8.90 vs. the industry median of 12.63, Healthconn has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Plans company?
The median EV-to-EBITDA among Healthcare Plans companies is 12.63, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthconn's current EV-to-EBITDA of 9.63 is 23.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Healthconn. For the Healthcare Plans industry, the median EV-to-EBITDA is 12.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthconn's current EV-to-EBITDA is 9.63, which is near median its own 10-year median of 8.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthconn stock overvalued right now?
Based on GuruFocus' analysis, Healthconn (ROCO:6665) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$22.26, compared to a current price of NT$17.65 — trading 20.7% below its estimated fair value. The current EV-to-EBITDA is 9.63, which is near median its 10-year median of 8.90 and 23.8% below the Healthcare Plans industry median of 12.63. Healthconn's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Healthconn (ROCO:6665), the current EV-to-EBITDA is 9.63 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthconn (ROCO:6665) Overvalued in 2026?
Based on GuruFocus' analysis, Healthconn stock appears to be undervalued.
The current stock price of NT$17.65 is trading 20.7% below its estimated GF Value™ of NT$22.26.
GuruFocus considers Healthconn to be Modestly Undervalued.
Key valuation signals for ROCO:6665:
EV-to-EBITDA: 9.63 (near median its 10-year median of 8.90)
GF Value™: NT$22.26 vs. price of NT$17.65 (20.7% below fair value)
Industry Position: 23.8% below the Healthcare Plans median (#4 of 15)
No single metric tells the full story. See the ROCO:6665 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthconn Corp is a Taiwan-based company engaged in the provisions of healthcare services. The company offers product and services such as personal services and corporate services, health monitoring, and others. In addition, it also provides weight management services.
81GF Score
Get the complete analysis for ROCO:6665
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6665 has been successfully added to your 
